Advertisement
Advertisement

IBO

IBO logo

Impact BioMedical, Inc.

0.43
USD
Sponsored
-0.01
-1.26%
Aug 11, 13:50 UTC -4
Closed
exchange

After-Market

0.43

0.00
+0.70%

Impact BioMedical, Inc. Profile

About

Impact BioMedical Inc. discovers, confirms and patents unique science and technologies resulting in new offerings in human healthcare and wellness. Impact BioMedical Inc. is based in NEW YORK.

Info & Links

CEO

Frank D. Heuszel

Headquarters

1400 BROADFIELD BLVD,SUITE 130
HOUSTON, TX 77084, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.impactbiomedinc.com

Auditor

GRASSI & CO., CPAs, P.C.

Share holders

556

Employees

8

Impact BioMedical, Inc. Statistics

Valuation Measures

Market Capitalization2

46.69M

Enterprise Value

46.68M

Enterprise Value/EBITDA(ttm)

-11.77

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

1.34K

Price to Book(mrq)

3.19

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

-1412.10%

Operating Margin(ttm)

2225.71%

Profit Margin(ttm)

-42713.09%

Return on Equity(ttm)

10.94%

Return on Invested Capital(ttm)

229.26%

Return on Assets(ttm)

4.43%

Income Statement

Revenue(ttm)

35.00K

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

-389.00K

EBITDA(ttm)3

-3.97M

Net Income Available to Common(ttm)

789.00K

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

2.73

52-Week Change

-26.47%

S&P 500 52-Week Change

21.26%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

107.82M

Dividend Yield

0.00%

Float4

11.86M

% Held by Insiders

89.00%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

10.00K

Total Cash Per Share(mrq)

0.00

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.22%

Quick Ratio(mrq)

0.19%

Book Value Per Share(mrq)

0.14

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.00

Free Cash Flow(ytd)

-464.00K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement